Analysts adjust ratings and price targets for Ingevity stock

In the last three months, four analysts have issued ratings for Ingevity (NYSE: NGVT), showing a mix of opinions. Recently, all analysts rated the stock as indifferent, a shift from two analysts being somewhat bearish two months ago. The average 12-month price target for Ingevity is now $42.25, down 1.74% from previous estimates. The highest target is $47.00, while the lowest is $40.00. Analysts from BMO Capital and Wells Fargo have adjusted their ratings and price targets. John McNulty from BMO Capital has lowered his target multiple times, while Michael Sison from Wells Fargo has also reduced his rating.